The third generation cephalosporin has a broad-spectrum antibacterial effect. This product is a third generation cephalosporin antibiotic produced against a variety of Gram-positive and Gram-negative bacteria. It has strong activity against Enterobacteriaceae. The MIC90 for Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Citrobacter fluorescens, indole-positive Proteus, Providencia and Serratia is between 0.12 and 0.25 mg/L. Enterobacter cloacae, Acinetobacter and Pseudomonas aeruginosa are poorly sensitive to this product. It has a strong antibacterial effect on Haemophilus influenzae, Neisseria gonorrhoeae and Neisseria meningitidis, and also has a good effect on hemolytic streptococci and pneumococci. The MIC for Staphylococcus aureus is 2 to 4 mg/L. Methicillin-resistant Staphylococci and enterococci are resistant to this product. Most Bacteroides fragilis are resistant to this product.

Extract from the above information

Isid is a semi-synthetic broad-spectrum penicillin antibiotic, mainly used to treat infections caused by Staphylococcus aureus, gonococci, diphtheria, Escherichia coli, Salmonella, Shigella dysenteriae and influenzae. It has the advantages of broad-spectrum antibacterial, fast oral effect, high efficacy, and low toxicity and side effects.

No specific pharmacological effects mentioned

Amoxicillin is a semi-synthetic broad-spectrum penicillin drug. Its antibacterial spectrum and antibacterial activity are basically the same as those of ampicillin, but its acid resistance is stronger than that of ampicillin. Its bactericidal effect is stronger and faster than that of the latter, but it cannot be used to treat meningitis. The half-life is about 61.3 minutes. Amoxicillin is stable under acidic conditions, and its gastrointestinal absorption rate reaches 90%, which is faster and more complete than that of ampicillin. Except for its poor effect on Shigella, the other effects are similar.